Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012-2018: Evidence from Claims Data of a Large Insurance

Details

Ressource 1Download: 34744596_BIB_9398DD83A25E.pdf (891.22 [Ko])
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_9398DD83A25E
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Change in Colorectal Cancer Tests Submitted for Reimbursement in Switzerland 2012-2018: Evidence from Claims Data of a Large Insurance
Journal
International Journal of Public Health
Author(s)
Schneider R., Näpflin M., Syrogiannouli L., Bissig S., Tal K., Bulliard J. L., Ducros C., Senn O., Selby K., Bähler C., Blozik E., Auer R.
ISSN
1661-8556 (Print)
1661-8556
Publication state
Published
Issued date
2021
Volume
66
Pages
1604073
Language
english
Notes
1661-8564
Schneider, Rémi
Näpflin, Markus
Syrogiannouli, Lamprini
Bissig, Sarah
Tal, Kali
Bulliard, Jean-Luc
Ducros, Cyril
Senn, Oliver
Selby, Kevin
Bähler, Caroline
Blozik, Eva
Auer, Reto
Journal Article
Int J Public Health. 2021 Oct 28;66:1604073. doi: 10.3389/ijph.2021.1604073. eCollection 2021.
Abstract
Objectives: Guidelines recommend colorectal cancer (CRC) screening by fecal occult blood test (FOBT) or colonoscopy. In 2013, Switzerland introduced reimbursement of CRC screening by mandatory health insurance for 50-69-years-olds, after they met their deductible. We hypothesized that the 2013 reimbursement policy increased testing rate. Methods: In claims data from a Swiss insurance, we determined yearly CRC testing rate among 50-75-year-olds (2012-2018) and the association with socio-demographic, insurance-, and health-related covariates with multivariate-adjusted logistic regression models. We tested for interaction of age (50-69/70-75) on testing rate over time. Results: Among insurees (2012:355'683; 2018:348'526), yearly CRC testing rate increased from 2012 to 2018 (overall: 8.1-9.9%; colonoscopy: 5.0-7.6%; FOBT: 3.1-2.3%). Odds ratio (OR) were higher for 70-75-year-olds (2012: 1.16, 95%CI 1.13-1.20; 2018: 1.05, 95%CI 1.02-1.08). Deductible interacted with changes in testing rate over time (p < 0.001). The increase in testing rate was proportionally higher among 50-69-years-olds than 70-75-year-olds over the years. Conclusions: CRC testing rate in Switzerland increased from 2012 to 2018, particularly among 50-69-years-olds, the target population of the 2013 law. Future studies should explore the effect of encouraging FOBT or waiving deductible.
Keywords
Swiss health insurance, colonoscopy, colorectal cancer screening, fecal occult blood test, testing rates, KS received personal fees from Kaiser Permanente Northern California and, non-financial support from the “Fondation vaudoise de dépistage du cancer”. EB, received grant supports from MSD, Novartis, Vifor, Amgen and the Swiss Cancer, Research Foundation outside of the topic of the submitted work. CB received grant, support from the Swiss National Research Program outside of the topic of the, submitted work. The remaining authors declare that the research was conducted in the, absence of any commercial or financial relationships that could be construed as a, potential conflict of interest.
Pubmed
Create date
15/11/2021 18:13
Last modification date
23/11/2022 8:13
Usage data